Home › Alzheimer's Disease › Utah › Salt Lake City
Alzheimer's Disease clinical trials in Salt Lake City, UT
4 studies for Alzheimer's Disease are looking for participants at sites in and around Salt Lake City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
RecruitingPhase 3
- Wasatch Clinical Research, LLC, Salt Lake City
Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
Recruiting
- University of Utah, Salt Lake City
Transforming Maternal Mental Health Care
RecruitingHealthy volunteers welcome
- University of Utah Hospital, Salt Lake City
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
RecruitingPhase 3
- University of Utah, Salt Lake City
About Alzheimer's Disease
Alzheimer's disease is a brain disorder that slowly destroys memory and thinking skills. It's the most common cause of dementia among older adults.
More about Alzheimer's Disease on MedlinePlus
Alzheimer's Disease trials in other cities
- Boston, MA26 studies
- Orlando, FL25 studies
- St. Louis, MO22 studies
- New York City, NY21 studies
- Miami, FL20 studies
- Tampa, FL17 studies
- Atlanta, GA16 studies
- The Villages, FL15 studies
- Philadelphia, PA15 studies
- Phoenix, AZ15 studies
- Indianapolis, IN14 studies
- Los Angeles, CA14 studies
Other studies in Salt Lake City
- Non-Small Cell Lung Cancer31 studies
- Cancer (all types)27 studies
- Breast Cancer27 studies
- Colorectal Cancer22 studies
- Lung Cancer21 studies
- Melanoma21 studies
- Multiple Myeloma21 studies
- Metastatic Cancer20 studies
- Ovarian Cancer19 studies
- Obesity18 studies
- Acute Myeloid Leukemia17 studies
- Heart Failure17 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.